Morrow Phuong Khanh has filed 11 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 2537 shares of Lantheus Holdings, Inc. ($LNTH) on May 14, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | Lantheus Holdings, Inc. | $LNTH | Morrow Phuong Khanh | Director | A | Common Stock | 2537 | $0.00 | 3,100.0000 | 71,651,000 | 450.62% | 0.00% |
| May 14, 2025 | Lantheus Holdings, Inc. | $LNTH | Morrow Phuong Khanh | Director | A | Stock Option (right to buy) | 4543 | $0.00 | 4,543.0000 | 71,651,000 | 9999.99% | 0.01% |
| Feb. 7, 2025 | Lantheus Holdings, Inc. | $LNTH | Morrow Phuong Khanh | Director | A | Stock Option (right to buy) | 1015 | $0.00 | 1,015.0000 | 71,651,000 | 9999.99% | 0.00% |
| Feb. 7, 2025 | Lantheus Holdings, Inc. | $LNTH | Morrow Phuong Khanh | Director | A | Stock Option (right to buy) | 1017 | $0.00 | 1,017.0000 | 71,651,000 | 9999.99% | 0.00% |
| Feb. 7, 2025 | Lantheus Holdings, Inc. | $LNTH | Morrow Phuong Khanh | Director | A | Common Stock | 563 | $0.00 | 563.0000 | 71,651,000 | 9999.99% | 0.00% |
| Oct. 13, 2023 | CRISPR Therapeutics AG | $CRSP | Morrow Phuong Khanh | Chief Medical Officer | A | Stock Option (Right to Buy) | 16667 | $0.00 | 16,667.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | CRISPR Therapeutics AG | $CRSP | Morrow Phuong Khanh | Chief Medical Officer | F | Common Shares | 2527 | $65.91 | 4,411.0000 | 0 | 36.42% | 0.00% |
| May 23, 2023 | CRISPR Therapeutics AG | $CRSP | Morrow Phuong Khanh | Chief Medical Officer | M | Restricted Stock Units | 6938 | $0.00 | 20,812.0000 | 0 | 50.01% | 0.00% |
| May 23, 2023 | CRISPR Therapeutics AG | $CRSP | Morrow Phuong Khanh | Chief Medical Officer | M | Common Shares | 6938 | $0.00 | 6,938.0000 | 0 | 9999.99% | 0.00% |
| March 10, 2023 | CRISPR Therapeutics AG | $CRSP | Morrow Phuong Khanh | Chief Medical Officer | A | Stock Option (Right to Buy) | 44620 | $0.00 | 44,620.0000 | 0 | 9999.99% | 0.00% |
| March 10, 2023 | CRISPR Therapeutics AG | $CRSP | Morrow Phuong Khanh | Chief Medical Officer | A | Restricted Stock Units | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |